Palatin Technologies, Inc. (PINK:PTNT – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $5.23 and traded as high as $7.00. Palatin Technologies shares last traded at $5.60, with a volume of 7,665 shares changing hands.
Palatin Technologies Stock Performance
The firm has a market capitalization of $145.66 million, a P/E ratio of -3.61 and a beta of 0.87. The business’s fifty day moving average is $5.60 and its 200 day moving average is $5.23.
About Palatin Technologies
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
See Also
- Five stocks we like better than Palatin Technologies
- Ride Out The Recession With These Dividend Kings
- Why Gold Loves Trump as Much as Trump Loves Gold
- What Are Some of the Best Large-Cap Stocks to Buy?
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- Compound Interest and Why It Matters When Investing
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
